Intraperitoneal chemotherapy in ovarian cancer

This publication has 79 references indexed in Scilit:

• Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse
  Cancer Gene Therapy, 1999
• A Phase II Trial of Intraperitoneal Cisplatin and Etoposide as Consolidation Therapy in Patients with Stage II–IV Epithelial Ovarian Cancer Following Negative Surgical Assessment
  Gynecologic Oncology, 1998
• Five-Year Survival after Second-Line Cisplatin-Based Intraperitoneal Chemotherapy for Advanced Ovarian Cancer
  Gynecologic Oncology, 1998
• Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer
  European Journal Of Cancer, 1995
• Phase I–II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer
  European Journal Of Cancer, 1993
• The Groshong Catheter as an Intraperitoneal Access Device in the Treatment of Ovarian Cancer Patients
  Gynecologic Oncology, 1993
• Intraperitoneal cisplatin chemotherapy in ovarian carcinoma patients who are clinically in complete remission
  Gynecologic Oncology, 1992
• Intraperitoneal human recombinant interferon alpha-2b in minimal residual ovarian cancer
  European Journal of Cancer and Clinical Oncology, 1990
• Escalating dose regimen of intraperitoneal mitoxantrone: Phase I study—clinical and pharmacokinetic evaluation
  European Journal of Cancer and Clinical Oncology, 1988
• Long-duration intracavitary infusion of methotrexate with systemic leucovorin protection in patients with malignant effusions.
  Journal of Clinical Investigation, 1981